<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000410743">
  <TermName>CP-547,632</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called vascular endothelial growth factor (VEGF) receptor inhibitors and angiogenesis inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>CP-547,632</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de medicamento  inhibidor del receptor del factor de crecimiento vascular endotelial (VEGFR) y un inhibidor de la angiogénesis.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-03-24</DateFirstPublished>
</GlossaryTerm>
